LJN452 (tropifexor) attenuates steatohepatitis, inflammation, and fibrosis in dietary mouse models of nonalcoholic steatohepatitis

Authors :: Bryan Laffitte
Chianelli Donatella
Jie Xu
Peter McNamara
Eloy D. Hernandez
D. Bao
B. Liu
Valentina Molteni
Yong-Chul Kim
Michael Badman
Paul Vincent Rucker
Jocelyn Zoll
Source :: Journal of Hepatology. 68:S341-S342
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Nonalcoholic steatohepatitis
medicine.medical_specialty
030505 public health
Hepatology
business.industry
Inflammation
medicine.disease
Gastroenterology
03 medical and health sciences
0302 clinical medicine
Fibrosis
Internal medicine
medicine
030212 general & internal medicine
medicine.symptom
Steatohepatitis
0305 other medical science
business

Full Text Access

Tools